Viewing StudyNCT06013969



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06013969
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-09
First Post: 2023-08-23

Brief Title: A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis GPP Who Need Treatment for Repeated Flares
Sponsor: Boehringer Ingelheim
Organization: Boehringer Ingelheim

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-10-11
Start Date Type: ACTUAL
Primary Completion Date: 2026-12-24
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-04-08
Completion Date Type: ESTIMATED
First Submit Date: 2023-08-23
First Submit QC Date: August 23 2023
Study First Post Date: 2023-08-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-30
Last Update Post Date: 2024-07-09
Last Update Post Date Type: ACTUAL